Business
Grant of options and PDMR Dealing
Animalcare Group PLC announced the grant of nil-cost options over 294,222 ordinary shares to Executive Directors and PDMRs under its LTIP, with vesting on 22 December 2028 contingent on EPS growth and Total Shareholder Return over the three years ending 31 December 2027. Specifically, 50% of the award is tied to EPS growth, with 100% vesting at 10% annual growth and 25% vesting at 3% annual growth, and the remaining 50% is linked to TSR ranking against a comparator group, with 100% vesting at upper quartile performance and 25% at median. Following these grants, Jennifer Winter holds 633,044 options and Chris Brewster holds 244,503 options. Disclaimer*
About this update from Animalcare Group Plc
[{"type":"text","content":"\n\n23 December 2025\nANIMALCARE GROUP PLC\n(\"Animalcare\" or the \"Company\")\nGrant of options and PDMR Dealing\nAnimalcare Group plc (AIM: ANCR), the international animal health business, announces that, on 22 December 2025, nil-cost options over a total of 294,222 ordinary shares with a nominal value of 20p per share (\"the Options\") were awarded to Executive Directors and PDMRs of Animalcare under the Company's Long Term Incentive Plan (\"LTIP\"). These are the only award of Options made to Executive Directors under the LTIP during the 2025 financial year.\nThe awards will vest on the third anniversary of award (22 December 2028) following the assessment of performance criteria based on Earnings Per Share (EPS) growth per annum and Total Shareholder Return (TSR) over the three-year financial period ending 31 December 2027. The use of EPS and TSR as performance metrics and the associated performance scale is unchanged from the most recent awards that were made in April 2024 for the three-year period ending 31 December 2026. Performance conditions for the Options are as follows:\n \n\n\n\n\n3-year Earnings Per Share growth per annum\n\n\nExtent to which EPS tranche will vest\n\n\n\n\nLess than 3%\n\n\n0%\n\n\n\n\n3%\n\n\n25%\n\n\n\n\n10%\n\n\n100%\n\n\n\n\nBetween 3% and 10%\n\n\nBetween 25% and 100% on a straight-line basis\n\n\n\n\n \n\n\n\n\nRank of the Company's TSR compared to the Comparator Group\n\n\nExtent to which the TSR tranche will vest\n\n\n\n\nUpper quartile or above\n\n\n100%\n\n\n\n\nBetween median and upper quartile\n\n\nPro rata between 25% and 100% on a ranking basis\n\n\n\n\nMedian\n\n\n25%\n\n\n\n\nBelow median\n\n\n0%\n\n\n\n\n \n50% of the Option award will be subject to the EPS performance condition and the remaining 50% will be subject to the TSR performance condition. Accordingly, if one of the performance conditions is met but the other is not, the Option award will only vest in part.\nAfter the grant of the Options, the PDMRs set out below hold the following Options and ordinary shares:\n \n\n\n\n\nPDMR\n\n\nOptions Awarded\n\n\nTotal Options\n\n\nOrdinary Shares\n\n\n\n\nJennifer Winter\n\n\n219,296\n\n\n633,044\n\n\n100,650\n\n\n\n\nChris Brewster\n\n\n74,926\n\n\n244,503\n\n\n283,513\n\n\n\n\n\nFrom the 2026 financial year and beyond we expect to make a...